In 2019, some of the worst performing stocks were in the biotech sector. Since peaking in March, the Nasdaq Biotechnology Index has dipped almost 7%.
So why are we bringing you biotech stocks to buy today?
In 2019, some of the worst performing stocks were in the biotech sector. Since peaking in March, the Nasdaq Biotechnology Index has dipped almost 7%.
So why are we bringing you biotech stocks to buy today?
Things are about to change for the entire biotech sector...
Right now, the biotech sector and Nasdaq are moving in lockstep.
Thus far in 2019, the iShares Nasdaq Biotechnology ETF (IBB) has gained 18.76%. By comparison, the technology-heavy Nasdaq index is up just over 19% this year.
Back in 1998, the same pattern was forming before biotech stocks truly broke out.
So despite the gains in the biotechnology sector in 2019, there are more gains to be had...
August was a robust month for penny stocks.
Just look at Seven Stars Cloud Group Inc.
On Friday (August 24), Seven Stars announced a $24 billion deal to finance China's nationwide push to replace all gas-powered public buses with electric vehicles by 2021.
The announcement pushed shares of Seven Star to $5.65, locking in a gain of 175% over Monday's (August 20) opening price of $3.00 a share.
Biotech firms offer extraordinary growth potential thanks to their development of new drugs.
If a drug wins FDA approval, the company's stock has the chance to rocket higher.
That's why we're bringing you the best biotech stocks to buy in September 2018...
Investors looking for triple-digit gains for little upfront investment often turn to penny stocks for promising returns.
That's why we're bringing you the three top penny stocks to watch in September 2018.
In order to makes sure we're investing in penny stocks that can deliver the strong returns we're looking for, we use the Money Morning Stock VQScore™ system.
Using the VQScore system, we screen for stocks that have the kind of robust financials to deliver stellar returns.
For retail investors, penny stocks are one of the best ways to grab 100% returns without breaking the bank. That's why we're bringing you the three penny stocks to buy in September 2018.
The numbers are staggering. Over the next six years, the biotech market is expected to add an additional $593 billion in value – a 419% increase over the size of today's biotech market.
Growth like this is why Wall Street is rushing hand over foot to buy the most lucrative biotech stocks available. With thousands of biotech stocks on the market, identifying the best biotech stocks to buy is incredibly difficult.
Three stocks have soared to the top of our Money Morning Stock VQScore™ rating system, but they won't be here much longer.
Learn how to capture double-digit returns with two and triple-digit returns with one of these investments.
Here's why we love all three of these stocks at these current prices...